Amneal Pharmaceuticals, Inc.
AMRX • NASDAQ
Amneal Pharmaceuticals, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Chirag K. Patel, with a market cap of $3.8B.
CEOChirag K. Patel
Next Earnings
Upcoming earnings announcement for Amneal Pharmaceuticals, Inc.
Date
Friday, May 1, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.16
Revenue Estimate
$713.0M
Earnings History
Past 12 earnings reports for Amneal Pharmaceuticals, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 27, 2026 | Q4 2025 | $0.21Est: $0.18 | +16.7% | $814.3MEst: $810.7M | +0.4% | — |
| Oct 30, 2025 | Q3 2025 | $0.17Est: $0.13 | +30.8% | $784.5MEst: $773.7M | +1.4% |  10-Q |
| Aug 5, 2025 | Q2 2025 | $0.25Est: $0.17 | +47.1% | $725.0MEst: $737.0M | -1.6% | 10-Q |
| May 2, 2025 | Q1 2025 | $0.21Est: $0.15 | +40.0% | $695.4MEst: $715.5M | -2.8% | 10-Q |
| Feb 28, 2025 | Q4 2024 | $0.12Est: $0.15 | -20.0% | $730.5MEst: $708.1M | +3.2% | 10-K |
| Nov 8, 2024 | Q3 2024 | $0.16Est: $0.13 | +23.1% | $702.5MEst: $696.8M | +0.8% | 10-Q |
| Aug 9, 2024 | Q2 2024 | $0.16Est: $0.14 | +14.3% | $701.8MEst: $658.1M | +6.6% | 10-Q |
| May 3, 2024 | Q1 2024 | $0.14Est: $0.09 | +55.6% | $659.2MEst: $619.0M | +6.5% | 10-Q |
| Mar 1, 2024 | Q4 2023 | $0.14Est: $0.09 | +55.6% | $617.0MEst: $634.2M | -2.7% | 10-K |
| Nov 7, 2023 | Q3 2023 | $0.19Est: $0.13 | +46.2% | $620.0MEst: $595.3M | +4.2% | — |
| Aug 4, 2023 | Q2 2023 | $0.19Est: $0.10 | +90.0% | $599.0MEst: $562.5M | +6.5% | 10-Q |
| May 5, 2023 | Q1 2023 | $0.12Est: $0.10 | +20.0% | $557.5MEst: $537.3M | +3.8% | 10-Q |